Home › Companies › C4 THERAPEUTICS INC. › 2023-2024
At C4 THERAPEUTICS INC.'s shareholder meeting held June 20, 2024, in the 2023-2024 proxy season, 93 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 387 separate fund positions. On the most widely held item on that ballot — To cast a non-binding, advisory vote to approve the compensation of our named executive… — FOR was 74% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: C4 THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 21, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and C4 THERAPEUTICS INC.’s Form 8-K, filed June 21, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 20, 2024: 5 items on C4 THERAPEUTICS INC.’s Form 8-K, filed June 21, 2024: 1 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore C4 THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are C4 THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kenneth Anderson, M.D. | 38,005,401 | -- | -- | 8,553,384 | 8,008,712 | 82% | Not verified | — |
| Elect Director: Laura Bessen, M.D. | 37,738,853 | -- | -- | 8,819,932 | 8,008,712 | 81% | Not verified | — |
| Elect Director: Owen Hughes | 27,472,145 | -- | -- | 19,086,640 | 8,008,712 | 59% | Not verified | — |
| B) The stockholders of the Company cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. | 34,500,552 | 11,936,841 | 121,392 | -- | 8,008,712 | 74% | Not verified | — |
| C) The stockholders of the Company ratified the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 54,362,556 | 170,867 | 34,074 | -- | -- | 99.6% | Approved | — |
Source: C4 THERAPEUTICS INC., Form 8-K, filed with the SEC on June 21, 2024 — read the filing on EDGAR.
Each item below shows how the 93 asset managers that disclosed a C4 THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors to our Board of Directors, each to serve until the 2027 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Kenneth Anderson, M.D.
C4 THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Anderson, M.D.”): 38,005,401 for, 8,553,384 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 26 asset managers below reported 12,406,346 for, 2,721,162 withheld, 43,170 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 6,680,805 | 0 | 0 | 9,165 | For |
| WASATCH FUNDS TRUST | 2,816,041 | 0 | 0 | 0 | For |
| Vanguard | 2,226,728 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 1,456,916 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 560,107 | Withhold |
| MERIDIAN FUND INC | 428,613 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 406,884 | Withhold |
| ProShares | 0 | 0 | 0 | 120,576 | Withhold |
| American Century | 0 | 0 | 0 | 92,448 | Withhold |
| HARBOR FUNDS | 73,399 | 0 | 0 | 0 | For |
| BlackRock | 58,898 | 0 | 0 | 0 | For |
| Charles Schwab | 52,485 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 49,000 | Withhold |
| Harbor ETF Trust | 31,984 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 30,407 | 0 | Abstain |
| Royce | 19,226 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 15,700 | Withhold |
| Jackson National | 0 | 0 | 12,763 | 0 | Abstain |
| Invesco | 12,128 | 0 | 0 | 0 | For |
| Fidelity | 0 | 0 | 0 | 8,462 | Withhold |
| Pacer Funds Trust | 3,668 | 0 | 0 | 0 | For |
| Equitable | 1,732 | 0 | 0 | 1,423 | Mixed |
| CITY NATIONAL ROCHDALE FUNDS | 543 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 460 | Withhold |
| SEI | 96 | 0 | 0 | 0 | For |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors to our Board of Directors, each to serve until the 2027 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Laura Bessen, M.D.
C4 THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laura Bessen, M.D.”): 37,738,853 for, 8,819,932 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 26 asset managers below reported 12,402,680 for, 2,724,828 withheld, 43,170 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 6,680,805 | 0 | 0 | 9,165 | For |
| WASATCH FUNDS TRUST | 2,816,041 | 0 | 0 | 0 | For |
| Vanguard | 2,226,728 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 1,456,916 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 560,107 | Withhold |
| MERIDIAN FUND INC | 428,613 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 406,884 | Withhold |
| ProShares | 0 | 0 | 0 | 120,576 | Withhold |
| American Century | 0 | 0 | 0 | 92,448 | Withhold |
| HARBOR FUNDS | 73,399 | 0 | 0 | 0 | For |
| BlackRock | 58,898 | 0 | 0 | 0 | For |
| Charles Schwab | 52,485 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 49,000 | Withhold |
| Harbor ETF Trust | 31,984 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 30,407 | 0 | Abstain |
| Royce | 19,226 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 15,700 | Withhold |
| Jackson National | 0 | 0 | 12,763 | 0 | Abstain |
| Invesco | 0 | 0 | 0 | 12,128 | Withhold |
| Fidelity | 8,462 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 3,668 | 0 | 0 | 0 | For |
| Equitable | 1,732 | 0 | 0 | 1,423 | Mixed |
| CITY NATIONAL ROCHDALE FUNDS | 543 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 460 | Withhold |
| SEI | 96 | 0 | 0 | 0 | For |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
59% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors to our Board of Directors, each to serve until the 2027 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Owen Hughes
C4 THERAPEUTICS INC.’s own tally for this item (“Elect Director: Owen Hughes”): 27,472,145 for, 19,086,640 withheld, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 59% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 26 asset managers below reported 5,187,142 for, 9,940,366 withheld, 43,170 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 7,091 | 0 | 0 | 6,682,879 | Withhold |
| WASATCH FUNDS TRUST | 2,816,041 | 0 | 0 | 0 | For |
| Vanguard | 2,226,728 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 1,456,916 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 560,107 | Withhold |
| MERIDIAN FUND INC | 0 | 0 | 0 | 428,613 | Withhold |
| Dimensional | 0 | 0 | 0 | 406,884 | Withhold |
| ProShares | 0 | 0 | 0 | 120,576 | Withhold |
| American Century | 0 | 0 | 0 | 92,448 | Withhold |
| HARBOR FUNDS | 73,399 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 58,898 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 52,485 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 49,000 | Withhold |
| Harbor ETF Trust | 31,984 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 30,407 | 0 | Abstain |
| Royce | 19,226 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 15,700 | Withhold |
| Jackson National | 0 | 0 | 12,763 | 0 | Abstain |
| Invesco | 0 | 0 | 0 | 12,128 | Withhold |
| Fidelity | 8,462 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 3,668 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 3,155 | Withhold |
| CITY NATIONAL ROCHDALE FUNDS | 543 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 460 | Withhold |
| SEI | 0 | 0 | 0 | 96 | Withhold |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: To cast a non-binding, advisory vote to approve the compensation of our named executive officers.
C4 THERAPEUTICS INC.’s own tally for this item (“b) The stockholders of the Company cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.”): 34,500,552 for, 11,936,841 against, per its Form 8-K filed June 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 6,680,805 | 9,165 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 2,816,041 | 0 | 0 | 0 | For |
| Vanguard | 0 | 2,226,728 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,456,916 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 560,107 | 0 | 0 | Against |
| MERIDIAN FUND INC | 428,613 | 0 | 0 | 0 | For |
| Dimensional | 0 | 406,884 | 0 | 0 | Against |
| ProShares | 0 | 120,576 | 0 | 0 | Against |
| American Century | 0 | 92,448 | 0 | 0 | Against |
| HARBOR FUNDS | 73,399 | 0 | 0 | 0 | For |
| BlackRock | 0 | 58,898 | 0 | 0 | Against |
| Charles Schwab | 52,485 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 49,000 | 0 | 0 | Against |
| Harbor ETF Trust | 31,984 | 0 | 0 | 0 | For |
| John Hancock | 0 | 30,407 | 0 | 0 | Against |
| Royce | 0 | 0 | 19,226 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 15,700 | 0 | 0 | Against |
| Jackson National | 0 | 12,763 | 0 | 0 | Against |
| Invesco | 0 | 12,128 | 0 | 0 | Against |
| Fidelity | 0 | 8,462 | 0 | 0 | Against |
| Pacer Funds Trust | 3,668 | 0 | 0 | 0 | For |
| Equitable | 0 | 3,155 | 0 | 0 | Against |
| CITY NATIONAL ROCHDALE FUNDS | 543 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 460 | 0 | 0 | Against |
| SEI | 96 | 0 | 0 | 0 | For |
Fund voting reports, all 26 managers: 10,087,634 for, 5,063,818 against, 19,226 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 6,711,555 | 9,838 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 4,767,818 | 0 | 0 | 0 | For |
| WASATCH ADVISORS LP | 3,520,602 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 3,410,384 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 2,297,108 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 1,960,702 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 1,361,683 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 1,276,574 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 0 | 1,146,717 | 0 | 0 | Against |
| Bain Capital Life Sciences Investors, LLC | 1,111,910 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 1,037,994 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 1,010,581 | 0 | 0 | Against |
| Two Sigma | 0 | 989,026 | 0 | 0 | Against |
| Point72 | 0 | 731,033 | 0 | 0 | Against |
| BlackRock | 981 | 638,290 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 0 | 560,107 | 0 | 0 | Against |
| Renaissance | 0 | 285,862 | 0 | 0 | Against |
| Atom Investors LP | 195,555 | 0 | 0 | 0 | For |
| DE Shaw | 0 | 195,520 | 0 | 0 | Against |
| Wellington | 176,890 | 0 | 0 | 0 | For |
| Citadel | 170,594 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 128,000 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 96,347 | 0 | 0 | Against |
| American Century | 0 | 92,448 | 0 | 0 | Against |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 77,867 | 0 | 0 | Against |
Institutional-manager reports, all 76 managers: 26,319,235 for, 8,160,719 against, 5,782 abstained, 3,346 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.6% Approved · of votes cast
Description as filed by funds: To ratify the engagement of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024.
C4 THERAPEUTICS INC.’s own tally for this item (“c) The stockholders of the Company ratified the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 54,362,556 for, 170,867 against — passed, per its Form 8-K filed June 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “c) The stockholders of the Company ratified the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 26 asset managers below reported 15,169,608 for, 1,070 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 6,688,900 | 1,070 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 2,816,041 | 0 | 0 | 0 | For |
| Vanguard | 2,226,728 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,456,916 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 560,107 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 428,613 | 0 | 0 | 0 | For |
| Dimensional | 406,884 | 0 | 0 | 0 | For |
| ProShares | 120,576 | 0 | 0 | 0 | For |
| American Century | 92,448 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 73,399 | 0 | 0 | 0 | For |
| BlackRock | 58,898 | 0 | 0 | 0 | For |
| Charles Schwab | 52,485 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 49,000 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 31,984 | 0 | 0 | 0 | For |
| John Hancock | 30,407 | 0 | 0 | 0 | For |
| Royce | 19,226 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 15,700 | 0 | 0 | 0 | For |
| Jackson National | 12,763 | 0 | 0 | 0 | For |
| Invesco | 12,128 | 0 | 0 | 0 | For |
| Fidelity | 8,462 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 3,668 | 0 | 0 | 0 | For |
| Equitable | 3,155 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 543 | 0 | 0 | 0 | For |
| Guggenheim | 460 | 0 | 0 | 0 | For |
| SEI | 96 | 0 | 0 | 0 | For |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 68,805,786 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 9.72% |
| 2 | WASATCH FUNDS TRUST | 4.09% |
| 3 | Vanguard | 3.24% |
| 4 | T. Rowe Price | 2.12% |
| 5 | Direxion Shares ETF Trust | 0.81% |
| 6 | MERIDIAN FUND INC | 0.62% |
| 7 | Dimensional | 0.59% |
| 8 | ProShares | 0.18% |
| 9 | American Century | 0.13% |
| 10 | HARBOR FUNDS | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 9.77% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 6.93% |
| 3 | WASATCH ADVISORS LP | 5.12% |
| 4 | COMMODORE CAPITAL LP | 4.96% |
| 5 | Soleus Capital Management, L.P. | 3.34% |
| 6 | T. Rowe Price | 2.85% |
| 7 | BALYASNY ASSET MANAGEMENT L.P. | 1.98% |
| 8 | TCG Crossover Management, LLC | 1.86% |
| 9 | Laurion Capital Management LP | 1.67% |
| 10 | Bain Capital Life Sciences Investors, LLC | 1.62% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| WASATCH ADVISORS LP | 10.86% | 13G |
| State Street | 10.40% | 13F |
| Betta Investment (Hong Kong) Limited | 8.09% | DEF14A |
| Betta Pharmaceuticals Co., Ltd. | 8.09% | 13G |
| Morgan Stanley | 7.23% | 13F |
| RA Capital Healthcare Fund L.P. | 7.09% | DEF14A |
| OrbiMed Capital LLC | 6.77% | 13G |
| Commodore Capital L.P. | 5.52% | DEF14A |
| Vanguard Group | 4.64% | 13F |
| T. Rowe Price | 3.07% | 13F |
Percentages above are of 68,805,786 shares outstanding, as reported by C4 THERAPEUTICS INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from C4 THERAPEUTICS INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
C4 THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “C4 THERAPEUTICS (CCCC) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/c4-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.